These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17132750)

  • 21. Methylene blue and sestamibi: complementary tools for localizing parathyroids.
    Orloff LA
    Laryngoscope; 2001 Nov; 111(11 Pt 1):1901-4. PubMed ID: 11801966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective evaluation of the efficacy of technetium 99m sestamibi and iodine 123 radionuclide imaging of abnormal parathyroid glands.
    Wei JP; Burke GJ; Mansberger AR
    Surgery; 1992 Dec; 112(6):1111-6; discussion 1116-7. PubMed ID: 1455313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Localization of parathyroid adenomas].
    Mjåland O; Normann E; Halvorsen E; Rynning S
    Tidsskr Nor Laegeforen; 2003 Mar; 123(5):648-50. PubMed ID: 12683196
    [No Abstract]   [Full Text] [Related]  

  • 24. Technetium Tc 99m sestamibi scan for localizing abnormal parathyroid glands after previous neck operations: preliminary experience in reoperative cases.
    Majors JD; Burke GJ; Mansberger AR; Wei JP
    South Med J; 1995 Mar; 88(3):327-30. PubMed ID: 7886531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands.
    Ishibashi M; Nishida H; Hiromatsu Y; Kojima K; Tabuchi E; Hayabuchi N
    J Nucl Med; 1998 Feb; 39(2):320-4. PubMed ID: 9476944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The complementary roles of fast spin-echo MR imaging and double-phase 99m Tc-sestamibi scintigraphy for localization of hyperfunctioning parathyroid glands.
    Lee VS; Spritzer CE; Coleman RE; Wilkinson RH; Coogan AC; Leight GS
    AJR Am J Roentgenol; 1996 Dec; 167(6):1555-62. PubMed ID: 8956597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost utility of routine imaging with Tc-99m-sestamibi in primary hyperparathyroidism before initial surgery.
    Wei JP; Burke GJ
    Am Surg; 1997 Dec; 63(12):1097-100; discussion 1100-1. PubMed ID: 9393259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Localization of parathyroid glands using technetium-99m-tetrofosmin imaging.
    Ishibashi M; Nishida H; Strauss HW; Kojima K; Fujito H; Watanabe J; Hiromatsu Y; Hayabuchi N
    J Nucl Med; 1997 May; 38(5):706-11. PubMed ID: 9170432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sestamibi scanning and minimally invasive radioguided parathyroidectomy without intraoperative parathyroid hormone measurement.
    Goldstein RE; Billheimer D; Martin WH; Richards K
    Ann Surg; 2003 May; 237(5):722-30; discussion 730-1. PubMed ID: 12724639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical role of 99mTcO4/MIBI scan, ultrasound and intra-operative gamma probe in the performance of unilateral and minimally invasive surgery in primary hyperparathyroidism.
    Casara D; Rubello D; Pelizzo MR; Shapiro B
    Eur J Nucl Med; 2001 Sep; 28(9):1351-9. PubMed ID: 11585294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving the yield of preoperative parathyroid localization: technetium Tc 99m-sestamibi imaging after thyroid suppression.
    Royal RE; Delpassand ES; Shapiro SE; Fritsche HA; Vassilopoulou-Sellin R; Sherman SI; Gagel RF; Evans DB; Lee JE
    Surgery; 2002 Dec; 132(6):968-74; discussion 974-5. PubMed ID: 12490843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlations between biochemical testing, pathology findings and preoperative sestamibi scans: a retrospective study of the minimally invasive radioguided parathyroidectomy (MIRP) approach.
    Stawicki SP; El Chaar M; Baillie DR; Jaik NP; Estrada FP
    Nucl Med Rev Cent East Eur; 2007; 10(2):82-6. PubMed ID: 18228211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localization procedures in patients with persistent or recurrent hyperparathyroidism.
    Rodriquez JM; Tezelman S; Siperstein AE; Duh QY; Higgins C; Morita E; Dowd CF; Clark OH
    Arch Surg; 1994 Aug; 129(8):870-5. PubMed ID: 8048861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An algorithm to maximize use of minimally invasive parathyroidectomy.
    Quiros RM; Alioto J; Wilhelm SM; Ali A; Prinz RA
    Arch Surg; 2004 May; 139(5):501-6; discussion 506-7. PubMed ID: 15136350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrasound facilitates minimally invasive parathyroidectomy in patients lacking definitive localization from preoperative sestamibi scan.
    Davis ML; Quayle FJ; Middleton WD; Acosta LM; Hix-Hernandez SJ; Snyder SK; Moley JF; Brunt LM; Lairmore TC
    Am J Surg; 2007 Dec; 194(6):785-90; discussion 790-1. PubMed ID: 18005772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative evaluation of hyperparathyroidism: the role of dual-phase parathyroid scintigraphy and ultrasound imaging.
    Sukan A; Reyhan M; Aydin M; Yapar AF; Sert Y; Canpolat T; Aktas A
    Ann Nucl Med; 2008 Feb; 22(2):123-31. PubMed ID: 18311537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia.
    Gayed IW; Kim EE; Broussard WF; Evans D; Lee J; Broemeling LD; Ochoa BB; Moxley DM; Erwin WD; Podoloff DA
    J Nucl Med; 2005 Feb; 46(2):248-52. PubMed ID: 15695783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Localization studies in patients with persistent or recurrent hyperparathyroidism.
    Clark OH; Okerlund MD; Moss AA; Stark D; Norman D; Newton TH; Duh QY; Arnaud CD; Harris S; Gooding GA
    Surgery; 1985 Dec; 98(6):1083-94. PubMed ID: 3906976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can localization studies be used to direct focused parathyroid operations?
    Arici C; Cheah WK; Ituarte PH; Morita E; Lynch TC; Siperstein AE; Duh QY; Clark OH
    Surgery; 2001 Jun; 129(6):720-9. PubMed ID: 11391371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative localization of parathyroid lesions in hyperparathyroidism: relationship between technetium-99m-MIBI uptake and oxyphil cell content.
    Carpentier A; Jeannotte S; Verreault J; Lefebvre B; Bisson G; Mongeau CJ; Maheux P
    J Nucl Med; 1998 Aug; 39(8):1441-4. PubMed ID: 9708524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.